{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:06:13Z","timestamp":1778583973827,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tamoxifen is used in clinical practice for breast cancer patients and to prevent osteoporosis. Red clover (<jats:italic>Trifolium pratense<\/jats:italic>) preparations are consumed worldwide as dietary supplements for relieving postmenopausal symptoms. In the present study we investigated the possible herb-drug interaction between red clover and tamoxifen in rats. 15 days pre-treatment with red clover did not alter the tamoxifen and its active metabolite 4-hydroxytamoxifen pharmacokinetics significantly (p\u2009&gt;\u20090.05). Therefore the therapeutic efficacy of the tamoxifen may not be compromised by the co-administration with red clover. Tamoxifen metabolism is primarily mediated by CYP2D6, CYP3A4 with minor contribution from CYP2C9, CYP2E1 and CYP1A2 isoforms. Although, red clover pre-treatment significantly (p\u2009&lt;\u20090.05) decreased the mRNA expression and activity of CYP3a2, no effect on CYP2d4 and increased expression and activity of CYP2c11 could be the plausible reasons for lack of effect on tamoxifen and its metabolite pharmacokinetics in rats. CYP1a1 and CYP2b2 mRNA expression and activity were also significantly reduced by red clover. To extend the clinical utility of the present study, effect of red clover extract on major CYPs using human liver microsomes and HepG2 cell lines were also determined. Similar finding were observed in the human liver preparations as in rats.<\/jats:p>","DOI":"10.1038\/srep16126","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T10:25:25Z","timestamp":1446632725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["No effect on pharmacokinetics of tamoxifen and 4-hydroxytamoxifen by multiple doses of red clover capsule in rats"],"prefix":"10.1038","volume":"5","author":[{"given":"Kanumuri Siva Rama","family":"Raju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guru Raghavendra","family":"Valicherla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali Krishna","family":"Challagundla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamunur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anees Ahmed","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaur Rahman","family":"Gayen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheelendra Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Wahajuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"key":"BFsrep16126_CR1","doi-asserted-by":"publisher","first-page":"1362S","DOI":"10.1093\/jn\/131.4.1362S","volume":"131","author":"KD Setchell","year":"2001","unstructured":"Setchell, K. D. et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 131, 1362S\u20131375S (2001).","journal-title":"J. Nutr."},{"key":"BFsrep16126_CR2","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1021\/jf025549r","volume":"50","author":"WH Tolleson","year":"2002","unstructured":"Tolleson, W. H., Doerge, D. R., Churchwell, M. I., Marques, M. M. & Roberts, D. W. Metabolism of biochanin A and formononetin by human liver microsomes in vitro. J. Agric. Food Chem. 50, 4783\u20134790 (2002).","journal-title":"J. Agric. Food Chem."},{"key":"BFsrep16126_CR3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1023\/A:1025044913766","volume":"20","author":"S Zhang","year":"2003","unstructured":"Zhang, S. & Morris, M. E. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells. Pharm. Res. 20, 1184\u20131191 (2003).","journal-title":"Pharm. Res."},{"key":"BFsrep16126_CR4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1124\/jpet.102.044412","volume":"304","author":"S Zhang","year":"2003","unstructured":"Zhang, S. & Morris, M. E. Effects of the flavonoids biochanin A, morin, phloretin and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther. 304, 1258\u20131267, 10.1124\/jpet.102.044412 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep16126_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijpharm.2007.01.002","volume":"337","author":"X Li","year":"2007","unstructured":"Li, X. & Choi, J. S. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int. J. Pharm. 337, 188\u2013193, 10.1016\/j.ijpharm.2007.01.002 (2007).","journal-title":"Int. J. Pharm."},{"key":"BFsrep16126_CR6","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/jps.20664","volume":"95","author":"SX Peng","year":"2006","unstructured":"Peng, S. X. et al. Altered oral bioavailability and pharmacokinetics of P-glycoprotein substrates by coadministration of biochanin A. J. Pharm. Sci. 95, 1984\u20131993, 10.1002\/jps.20664 (2006).","journal-title":"J. Pharm. Sci."},{"key":"BFsrep16126_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ptr.3652","volume":"26","author":"SP Singh","year":"2012","unstructured":"Singh, S. P. et al. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats. Phytother. Res. 26, 303\u2013307, 10.1002\/ptr.3652 (2012).","journal-title":"Phytother. Res."},{"key":"BFsrep16126_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/jps.21827","volume":"99","author":"S Zhang","year":"2010","unstructured":"Zhang, S. et al. Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: in vitro and in vivo. J. Pharm. Sci. 99, 430\u2013441, 10.1002\/jps.21827 (2010).","journal-title":"J. Pharm. Sci."},{"key":"BFsrep16126_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/1389200211314040002","volume":"14","author":"Wahajuddin","year":"2013","unstructured":"Wahajuddin, Taneja, I., Arora, S., Raju, K. S. & Siddiqui, N. Disposition of pharmacologically active dietary isoflavones in biological systems. Cur. Drug Metabol. 14, 369\u2013380 (2013).","journal-title":"Cur. Drug Metabol."},{"key":"BFsrep16126_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1007\/s11095-010-0108-8","volume":"27","author":"G An","year":"2010","unstructured":"An, G. & Morris, M. E. Effects of single and multiple flavonoids on BCRP-mediated accumulation, cytotoxicity and transport of mitoxantrone in vitro. Pharm. Res. 27, 1296\u20131308, 10.1007\/s11095-010-0108-8 (2010).","journal-title":"Pharm. Res."},{"key":"BFsrep16126_CR11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1023\/B:PHAM.0000048202.92930.61","volume":"21","author":"J Chen","year":"2004","unstructured":"Chen, J., Halls, S. C., Alfaro, J. F., Zhou, Z. & Hu, M. Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes. Pharm. Res. 21, 2095\u20132104 (2004).","journal-title":"Pharm. Res."},{"key":"BFsrep16126_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbrc.2004.03.040","volume":"317","author":"HC Cooray","year":"2004","unstructured":"Cooray, H. C., Janvilisri, T., van Veen, H. W., Hladky, S. B. & Barrand, M. A. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem. Biophys. Res. Commun. 317, 269\u2013275, 10.1016\/j.bbrc.2004.03.040 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep16126_CR13","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1007\/s11095-010-0208-5","volume":"27","author":"G Merino","year":"2010","unstructured":"Merino, G. et al. In vivo inhibition of BCRP\/ABCG2 mediated transport of nitrofurantoin by the isoflavones genistein and daidzein: a comparative study in Bcrp1 (\u2212\/\u2212) mice. Pharm. Res. 27, 2098\u20132105, 10.1007\/s11095-010-0208-5 (2010).","journal-title":"Pharm. Res."},{"key":"BFsrep16126_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/00498250310001615762","volume":"33","author":"S Mesia-Vela","year":"2003","unstructured":"Mesia-Vela, S. & Kauffman, F. C. Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica; the fate of foreign compounds in biological systems 33, 1211\u20131220, 10.1080\/00498250310001615762 (2003).","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"BFsrep16126_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0091270005285199","volume":"46","author":"M Nakajima","year":"2006","unstructured":"Nakajima, M. et al. Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6. J. Clin. Pharmacol. 46, 337\u2013344, 10.1177\/0091270005285199 (2006).","journal-title":"J. Clin. Pharmacol."},{"key":"BFsrep16126_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jps.10283","volume":"92","author":"H Nguyen","year":"2003","unstructured":"Nguyen, H., Zhang, S. & Morris, M. E. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J. Pharm. Sci. 92, 250\u2013257, 10.1002\/jps.10283 (2003).","journal-title":"J. Pharm. Sci."},{"key":"BFsrep16126_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00228-003-0596-0","volume":"59","author":"WX Peng","year":"2003","unstructured":"Peng, W. X., Li, H. D. & Zhou, H. H. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers. Eur. J. Clin. Pharmacol. 59, 237\u2013241, 10.1007\/s00228-003-0596-0 (2003).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFsrep16126_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2885.2008.01050.x","volume":"32","author":"M Perez","year":"2009","unstructured":"Perez, M. et al. Milk secretion of nitrofurantoin, as a specific BCRP\/ABCG2 substrate, in assaf sheep: modulation by isoflavones. J. Vet. Pharmacol. Ther. 32, 498\u2013502, 10.1111\/j.1365-2885.2008.01050.x (2009).","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"BFsrep16126_CR19","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0006-2952(94)90149-X","volume":"48","author":"CH Versantvoort","year":"1994","unstructured":"Versantvoort, C. H., Broxterman, H. J., Lankelma, J., Feller, N. & Pinedo, H. M. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Biochem. Pharmacol. 48, 1129\u20131136 (1994).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep16126_CR20","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/bjc.1993.458","volume":"68","author":"CH Versantvoort","year":"1993","unstructured":"Versantvoort, C. H. et al. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer 68, 939\u2013946 (1993).","journal-title":"Br. J. Cancer"},{"key":"BFsrep16126_CR21","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1124\/dmd.105.005926","volume":"33","author":"X Wang","year":"2005","unstructured":"Wang, X., Wolkoff, A. W. & Morris, M. E. Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators. Drug Metab. Dispos. 33, 1666\u20131672, 10.1124\/dmd.105.005926 (2005).","journal-title":"Drug Metab. Dispos."},{"key":"BFsrep16126_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2015.08.202","volume":"239","author":"S Arora","year":"2015","unstructured":"Arora, S., Taneja, I., Challagundla, M., Raju, K. S. R., Singh, S. P. & Wahajuddin, M. In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data. Toxicol. let. 239, 1\u20138 (2015).","journal-title":"Toxicol. let."},{"key":"BFsrep16126_CR23","first-page":"261","volume":"76","author":"A Tripathi","year":"2014","unstructured":"Tripathi, A., Singh, S. P., Raju, K. S., Wahajuddin & Gayen, J. R. Effect of Red Clover on CYP Expression: An Investigation of Herb-Drug Interaction at Molecular Level. Indian J. Pharm. Sci. 76, 261\u2013266 (2014).","journal-title":"Indian J. Pharm. Sci."},{"key":"BFsrep16126_CR24","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/0006-2952(91)90131-N","volume":"41","author":"F Jacolot","year":"1991","unstructured":"Jacolot, F. et al. Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes. Biochem. Pharmacol. 41, 1911\u20131919 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep16126_CR25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0090-9556(25)07469-0","volume":"21","author":"C Mani","year":"1993","unstructured":"Mani, C., Hodgson, E. & Kupfer, D. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation. Drug Metab. Dispos. 21, 657\u2013661 (1993).","journal-title":"Drug Metab. Dispos."},{"key":"BFsrep16126_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0006-2952(96)00650-8","volume":"53","author":"HK Crewe","year":"1997","unstructured":"Crewe, H. K., Ellis, S. W., Lennard, M. S. & Tucker, G. T. Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. Biochem. Pharmacol. 53, 171\u2013178 (1997).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep16126_CR27","first-page":"317","volume":"42","author":"E Coezy","year":"1982","unstructured":"Coezy, E., Borgna, J. L. & Rochefort, H. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res. 42, 317\u2013323 (1982).","journal-title":"Cancer Res."},{"key":"BFsrep16126_CR28","first-page":"112","volume":"44","author":"BS Katzenellenbogen","year":"1984","unstructured":"Katzenellenbogen, B. S., Norman, M. J., Eckert, R. L., Peltz, S. W. & Mangel, W. F. Bioactivities, estrogen receptor interactions and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 44, 112\u2013119 (1984).","journal-title":"Cancer Res."},{"key":"BFsrep16126_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0006-2952(94)90099-X","volume":"48","author":"US Rao","year":"1994","unstructured":"Rao, U. S., Fine, R. L. & Scarborough, G. A. Antiestrogens and steroid hormones: substrates of the human P-glycoprotein. Biochem. Pharmacol. 48, 287\u2013292 (1994).","journal-title":"Biochem. Pharmacol."},{"key":"BFsrep16126_CR30","first-page":"105","volume":"2","author":"Y Sugimoto","year":"2003","unstructured":"Sugimoto, Y. et al. Reversal of breast cancer resistance protein-mediated drug resistance by estrogen antagonists and agonists. Mol. Cancer Ther. 2, 105\u2013112 (2003).","journal-title":"Mol. Cancer Ther."},{"key":"BFsrep16126_CR31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-9556(25)07102-8","volume":"19","author":"SP Robinson","year":"1991","unstructured":"Robinson, S. P., Langan-Fahey, S. M., Johnson, D. A. & Jordan, V. C. Metabolites, pharmacodynamics and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metabol. Dispos. 19, 36\u201343 (1991).","journal-title":"Drug Metabol. Dispos."},{"key":"BFsrep16126_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/carcin\/15.4.589","volume":"15","author":"CK Lim","year":"1994","unstructured":"Lim, C. K. et al. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. Carcinogenesis 15, 589\u2013593 (1994).","journal-title":"Carcinogenesis"},{"key":"BFsrep16126_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/FPC.0b013e3283656bc1","volume":"23","author":"DJ Klein","year":"2013","unstructured":"Klein, D. J., Thorn, C. F., Desta, Z., Flockhart, D. A., Altman, R. B. & Klein, T. E. PharmGKB summary: tamoxifen pathway, pharmacokinetics. Pharmacogenet. Genomics. 23, 643\u2013647, 10.1097\/FPC.0b013e3283656bc1 (2013).","journal-title":"Pharmacogenet. Genomics."},{"key":"BFsrep16126_CR34","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1093\/jnci\/djg108","volume":"95","author":"V Stearns","year":"2003","unstructured":"Stearns, V. et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J. Natl. Cancer Inst. 95, 1758\u20131764 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFsrep16126_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/jpet.104.065607","volume":"310","author":"Z Desta","year":"2004","unstructured":"Desta, Z., Ward, B. A., Soukhova, N. V. & Flockhart, D. A. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. J. Pharmacol. Exp. Ther. 310, 1062\u20131075, 10.1124\/jpet.104.065607 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFsrep16126_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2133\/dmpk.DMPK-11-RV-084","volume":"27","author":"K Kiyotani","year":"2012","unstructured":"Kiyotani, K., Mushiroda, T., Nakamura, Y. & Zembutsu, H. Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters. Drug Metab. Pharmacokinet. 27, 122\u2013131 (2012).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"BFsrep16126_CR37","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1023\/B:PHAM.0000048202.92930.61","volume":"21","author":"J Chen","year":"2004","unstructured":"Chen, J., Halls, S. C., Alfaro, J. F., Zhou, Z. & Hu, M. Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes. Pharm. Res. 21, 2095\u20132104 (2004).","journal-title":"Pharm. Res."},{"key":"BFsrep16126_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/107555302317371424","volume":"8","author":"J Howes","year":"2002","unstructured":"Howes, J., Waring, M., Huang, L. & Howes, L. G. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J. Altern. Complement Med. 8, 135\u2013142, 10.1089\/107555302317371424 (2002).","journal-title":"J. Altern. Complement Med."},{"key":"BFsrep16126_CR39","doi-asserted-by":"crossref","unstructured":"Raju, K. S., Kadian, N., Taneja, I. & Wahajuddin, M. Phytochemical analysis of isoflavonoids using liquid chromatography coupled with tandem mass spectrometry. Phytochem. Rev. 1\u201330, 10.1007\/s11101-015-9400-x (2015).","DOI":"10.1007\/s11101-015-9400-x"},{"key":"BFsrep16126_CR40","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4155\/bio.14.253","volume":"7","author":"KS Rama Raju","year":"2015","unstructured":"Rama Raju, K. S. et al. Simultaneous determination of centchroman and tamoxifen along with their metabolites in rat plasma using LC-MS\/MS. Bioanalysis 7, 967\u2013979, 10.4155\/bio.14.253 (2015).","journal-title":"Bioanalysis"},{"key":"BFsrep16126_CR41","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1016\/j.jchromb.2011.07.036","volume":"879","author":"SP Singh","year":"2011","unstructured":"Singh, S. P., Wahajuddin, Ali, M. M., Kohli, K. & Jain, G. K. Liquid chromatography-mass spectrometry method for the quantification of tamoxifen and its metabolite 4-hydroxytamoxifen in rat plasma: application to interaction study with biochanin A (an isoflavone). J. Chromatogr. B. 879, 2845\u20132851, 10.1016\/j.jchromb.2011.07.036 (2011).","journal-title":"J. Chromatogr. B."},{"key":"BFsrep16126_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:54:50Z","timestamp":1748681690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,21]]}},"alternative-id":["BFsrep16126"],"URL":"https:\/\/doi.org\/10.1038\/srep16126","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]},"assertion":[{"value":"1 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16126"}}